SelectQuote: Expects annual expense savings of over $30 mln exiting 2026

SelectQuote Inc. (SLQT) is projected to achieve annual expense savings exceeding $30 million by the end of 2026, according to recent analyst forecasts. This anticipated reduction in costs is attributed to ongoing operational efficiencies and strategic workforce adjustments. However, the company faces challenges, including a projected 3.9% decline in approved Medicare Advantage (MA) policies for fiscal 2025, primarily due to a reduced headcount and potential persistency headwinds that could negatively impact revenue and cash flow from commissions.

Despite these challenges, SelectQuote's Healthcare Services segment is expected to drive growth, with an adjusted growth estimate for Medicare Advantage approved policies raised to 6.5% for fiscal 2026. This segment is seen as a key driver of revenue visibility and business stability. Analysts have assigned a consensus rating of Hold for SelectQuote, with no recommendations for Strong Buy or Buy. The current price target remains unchanged at $3, reflecting a 0.00% increase from current stock price. Investors are advised to monitor the company's quarterly results and strategic initiatives as they progress toward the anticipated expense reductions.